Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project

Haematologica. 2018 Sep;103(9):e392-e394. doi: 10.3324/haematol.2017.185751. Epub 2018 Apr 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Biopsy
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Chromosome Aberrations*
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polycythemia Vera / genetics*
  • Polycythemia Vera / mortality
  • Polycythemia Vera / pathology
  • Primary Myelofibrosis / genetics*
  • Primary Myelofibrosis / mortality
  • Primary Myelofibrosis / pathology
  • Prognosis
  • Thrombocythemia, Essential / genetics*
  • Thrombocythemia, Essential / mortality
  • Thrombocythemia, Essential / pathology

Substances

  • Biomarkers